Scailyte
Latest round
- Series A
Last raised
- Jan 2022
Total raised
- $9.3M
Investors
- 4
About Scailyte
a. Scailyte, operates as a developer of precision medicine for disease patterns from single-cell data., a portfolio company of Coyote Ventures, Althea Group Ventures, Kendra Scott Women’s Entrepreneurial Leadership Institute, and Stella Angels agreed to acquire Scailyte AG from Mirabaud Asset Management, Swisscom Ventures, Venture Kick, 4FO Ventures, Zürcher Kantonalbank, investiere, and Hemex AG. Scailyte specializes in discovering predictive biomarkers and designing companion diagnostics in immunology and oncology using single-cell omics and AI. The company’s AI discovery platform, ScaiVision, enables precise biomarker identification for improved therapy responses and disease diagnosis. The company plans to use its proceeds from the January 2024 acquisition to expand its diagnostic programs for endometriosis.
Who invested in Scailyte
4 investors across 2 rounds
See all investors in Scailyte
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Scailyte
Who invested in Scailyte?
Scailyte has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Scailyte raised?
Scailyte has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Scailyte last raise money?
Scailyte's most recent round on record is a Series A, in Jan 2022.
What does Scailyte do?
Scailyte is a biotechnology company.
Where is Scailyte headquartered?
Scailyte is headquartered in Basel, Switzerland.
Which VCs invest in companies like Scailyte?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Scailyte's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Scailyte? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.